eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
At close: Sep 2, 2026
eFFECTOR Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -34.63 | -35.81 | -22.67 | 15.8 | 0.17 | -14.21 |
Depreciation & Amortization | 0.11 | 0.11 | 0.05 | 0.02 | 0.16 | 0.31 |
Loss (Gain) From Sale of Assets | -0 | -0 | 0 | - | -0.32 | -0.02 |
Loss (Gain) From Sale of Investments | -0.41 | -0.47 | -0.04 | - | - | - |
Stock-Based Compensation | 4.44 | 4.6 | 5.33 | 8.66 | 0.5 | 0.65 |
Other Operating Activities | 0.35 | 0.35 | -11.26 | -49.13 | 14.16 | -15.4 |
Change in Accounts Payable | -2.09 | 0.86 | 0.96 | 0.16 | -0.25 | -0.73 |
Change in Other Net Operating Assets | 3.04 | 0.83 | 1.72 | -0.39 | -0.57 | 1.8 |
Operating Cash Flow | -29.19 | -29.55 | -25.9 | -24.89 | 13.84 | -27.6 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Capital Expenditures | -0.08 | -0.1 | -0.19 | -0.04 | -0.15 | -0 |
Sale of Property, Plant & Equipment | - | - | - | 0.61 | - | 0.09 |
Investment in Securities | -0.78 | 14.58 | -17.67 | - | - | - |
Investing Cash Flow | -0.86 | 14.48 | -17.86 | 0.57 | -0.15 | 0.08 |
Financing Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Long-Term Debt Issued | - | - | - | 19.84 | - | - |
Long-Term Debt Repaid | - | - | - | -13.94 | -2 | - |
Net Debt Issued (Repaid) | -0.56 | - | - | 5.9 | -2 | - |
Issuance of Common Stock | 35.81 | 21.23 | 2.8 | 52.91 | 0.11 | - |
Repurchase of Common Stock | - | - | - | - | - | -0.09 |
Other Financing Activities | - | - | -0.04 | - | - | -0.09 |
Financing Cash Flow | 35.25 | 21.23 | 2.77 | 58.81 | -1.89 | 20.24 |
Net Cash Flow
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Cash Flow | 5.2 | 6.17 | -40.99 | 34.49 | 11.79 | -7.27 |
Free Cash Flow
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Free Cash Flow | -29.28 | -29.65 | -26.09 | -24.93 | 13.68 | -27.6 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | -734.34% | -1743.36% | 32.57% | - |
Free Cash Flow Per Share | -10.50 | -13.56 | -15.84 | -17.31 | 128.83 | -577.02 |
Levered Free Cash Flow | -17.67 | -17.73 | -14.05 | -13.06 | 8.12 | - |
Unlevered Free Cash Flow | -15.8 | -15.91 | -12.65 | -11.96 | 8.95 | - |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash Interest Paid | 2.6 | 2.53 | 1.82 | 1.34 | 0.98 | 1.04 |
Change in Working Capital | 0.95 | 1.69 | 2.68 | -0.24 | -0.82 | 1.07 |